» Articles » PMID: 31609581

Hyperthermia and Controllable Free Radical Coenhanced Synergistic Therapy in Hypoxia Enabled by Near-Infrared-II Light Irradiation

Overview
Journal ACS Nano
Specialty Biotechnology
Date 2019 Oct 15
PMID 31609581
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor cell metabolism and tumor blood vessel proliferation are distinct from normal cells. The resulting tumor microenvironment presents a characteristic of hypoxia, which greatly limits the generation of oxygen free radicals and affects the therapeutic effect of photodynamic therapy. Here, we developed an oxygen-independent free radical generated nanosystem (CuFeSe-AIPH@BSA) with dual-peak absorption in both near-infrared (NIR) regions and utilized it for imaging-guided synergistic treatment. The special absorption provides the nanosystem with high photothermal conversion efficiency and favorably matched photoactivity in both I and II NIR biological windows. Upon NIR light irradiation, the generated heat could prompt AIPH release and decompose to produce oxygen-independent free radicals for killing cancer cells effectively. The contrastive research results show that the enhanced therapeutic efficacy of NIR-II over NIR-I is principally due to its deeper tissue penetration and higher maximum permission exposure that benefits from a longer wavelength. Hyperthermia effect and the production of toxic free radicals upon NIR-II laser illumination are extremely effective in triggering apoptosis and death of cancer cells in the tumor hypoxia microenvironment. The high biocompatibility and excellent anticancer efficiency of CuFeSe-AIPH@BSA allow it to be an ideal oxygen-independent nanosystem for imaging-guided and NIR-II-mediated synergistic therapy systemic administration.

Citing Articles

Microfluidic-Assisted Silk Nanoparticles Co-Loaded with Epirubicin and Copper Sulphide: A Synergistic Photothermal-Photodynamic Chemotherapy Against Breast Cancer.

Gao Z, Mansor M, Howard F, MacInnes J, Zhao X, Muthana M Nanomaterials (Basel). 2025; 15(3).

PMID: 39940197 PMC: 11820260. DOI: 10.3390/nano15030221.


A free-radical initiator-based carrier-free smart nanobomb for targeted synergistic therapy of hypoxic breast cancer.

Hu L, Dong G, Li X, Li S, Lv Y RSC Adv. 2025; 15(5):3098-3109.

PMID: 39885853 PMC: 11780488. DOI: 10.1039/d4ra07841a.


Boosting the sonodynamic performance of CoBiMn-layered double hydroxide nanoparticles via tumor microenvironment regulation for ultrasound imaging-guided sonodynamic therapy.

Yang S, Hu T, Williams G, Yang Y, Zhang S, Shen J J Nanobiotechnology. 2024; 22(1):317.

PMID: 38849886 PMC: 11161954. DOI: 10.1186/s12951-024-02591-5.


Nanomaterials-Induced Redox Imbalance: Challenged and Opportunities for Nanomaterials in Cancer Therapy.

Wu X, Zhou Z, Li K, Liu S Adv Sci (Weinh). 2024; 11(16):e2308632.

PMID: 38380505 PMC: 11040387. DOI: 10.1002/advs.202308632.


Photoresponsive Inorganic Nanomaterials in Oncology.

Barbero F, Gul S, Perrone G, Fenoglio I Technol Cancer Res Treat. 2023; 22:15330338231192850.

PMID: 37551087 PMC: 10408349. DOI: 10.1177/15330338231192850.